Literature DB >> 10457902

Implication of vascular endothelial growth factor in the development and metastasis of human cancers.

S Arii1, A Mori, S Uchida, K Fujimoto, Y Shimada, M Imamura.   

Abstract

Vascular endothelial growth factor (VEGF) is a most potent angiogenic molecule. In this article, we demonstrated that VEGF is participated in the tumor angiogenesis of hepatocellular carcinoma, esophageal cancer, and pancreatic cancer. Furthermore, we revealed that VEGF is one of the molecules which are responsible for metastasis and prognosis in esophageal cancer and colon cancer. Although the mechanism on the induction of VEGF gene is still unclear in human cancer tissue, we obtained the informative evidence indicating that p53 mutation is involved in VEGF expression of esophageal cancer. Our experimental study with stable transfectant of VEGF gene provided the confirmative results showing that VEGF gene induces neovascularization in and around tumor and that VEGF augment metastastic potential by accelerating proliferative activity after reaching the target organ.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457902

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  8 in total

1.  Upregulation of vascular endothelial growth factor by hydrogen peroxide in human colon cancer.

Authors:  Jian-Wei Zhu; Bao-Ming Yu; Yu-Bao Ji; Ming-Hua Zheng; Dong-Hua Li
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Gene transfer of somatostatin receptor type 2 by intratumoral injection inhibits established pancreatic carcinoma xenografts.

Authors:  Zhi-Yong Du; Ren-Yi Qin; Wei Xia; Rui Tian; Manoj Kumar
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

3.  The role of cystatin C and the angiogenic cytokines VEGF and bFGF in patients with esophageal carcinoma.

Authors:  Martin Dreilich; Gunnar Wagenius; Stefan Bergström; Daniel Brattström; Anders Larsson; Patrik Hesselius; Michael Bergqvist
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

4.  Analysis of p53 and vascular endothelial growth factor expression in human gallbladder carcinoma for the determination of tumor vascularity.

Authors:  Yu Tian; Ren-Yu Ding; Ying-Hui Zhi; Ren-Xuan Guo; Shuo-Dong Wu
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

Review 5.  Apoptosis: targets in pancreatic cancer.

Authors:  Sabine Westphal; Holger Kalthoff
Journal:  Mol Cancer       Date:  2003-01-07       Impact factor: 27.401

6.  An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation.

Authors:  S Cascinu; F Graziano; V Catalano; M P Staccioli; M C Rossi; A M Baldelli; S Barni; A Brenna; S Secondino; P Muretto; G Catalano
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

7.  Expression of vascular endothelial growth factor and p53 in pancreatic carcinomas.

Authors:  Young Eun Joo; Young Hae Sohn; Wan Sik Lee; Chang Hwan Park; Sung Kyu Choi; Jong Sun Rew; Chang Soo Park; Sei Jong Kim
Journal:  Korean J Intern Med       Date:  2002-09       Impact factor: 2.884

Review 8.  New targeted therapies in gastrointestinal cancers.

Authors:  Sharlene Gill; Rebecca R Thomas; Richard M Goldberg
Journal:  Curr Treat Options Oncol       Date:  2003-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.